Assay of Tromethamine in Pharmaceutical Formulations

Importance of the Topic

The accurate measurement of tromethamine in pharmaceutical formulations is vital for quality control, regulatory compliance, and ensuring patient safety. Tromethamine serves as a buffering agent in many injectable and topical products, and its reliable assay supports consistent dosage and therapeutic performance.

Objectives and Study Overview

This work aimed to establish and validate a high-performance ion chromatography (HPIC) method with suppressed conductivity detection for tromethamine in complex formulations. The study followed ICH and USP <1225> guidelines to assess linearity, precision, accuracy, sensitivity, and robustness across multiple chromatographic conditions.

Methodology and Instrumentation

The separation used a Thermo Scientific Dionex IonPac CS20 analytical column (2×250 mm) with a CG20 guard (2×50 mm) under isocratic elution. Key operating conditions:

• Eluent: 2 mM methanesulfonic acid (MSA) generated in-line
• Flow rate: 0.3 mL/min
• Column temperature: 40 °C
• Injection volume: 2.5 µL (full-loop)
• Detection: Suppressed conductivity via CDRS 600 suppressor
• Instrumentation: Dionex Integrion HPIC system with automated eluent generation and Dionex Viper fittings

Main Results and Discussion

Separation of tromethamine from common cations (sodium, ammonium) was achieved within a 30 min run. Resolution values exceeded 1.6 for adjacent peaks. Linearity was confirmed over 1–50 mg/L with a quadratic fit (R2 ≈ 1.000). Precision (n=3) at 2, 5, and 10 ppm showed RSDs ≤ 0.85% for retention time and peak area. Method sensitivity delivered LOD 0.05 ppm and LOQ 0.15 ppm. Accuracy in a simulated vaccine excipient matrix yielded recoveries between 95% and 112% across spike levels (5, 10, 25 ppm). Robustness tests on two columns introduced ±10% variations in eluent concentration, flow rate, and temperature, demonstrating minimal impact on retention time, asymmetry, and resolution.

Benefits and Practical Applications

This HPIC approach offers:

• Simultaneous determination of tromethamine and common cationic excipients
• High specificity without derivatization
• Automated eluent generation for reproducibility
• Compliance with pharmacopeial requirements for assay validation

Future Trends and Applications

Advances may include shorter column formats or higher-throughput systems to reduce analysis time. Coupling with mass spectrometry could further enhance selectivity for trace impurities. Application of this method to related substances and stability testing is anticipated.

Conclusion

A robust, validated HPIC method for tromethamine quantitation has been developed, meeting accuracy, precision, and sensitivity criteria. The procedure is suitable for routine quality control of pharmaceutical formulations and can be extended to related analyte testing.

References

1. U.S. Pharmacopeial Convention, Tromethamine, USP43-NF38
2. Analyst 1988, 113, 755
3. J. Chromatogr. 1992, 583, 99
4. J. Anal. Toxicol. 1984, 8, 231
5. J. Pharm. Biomed. Anal. 2003, 31(6), 1191–1201
6. J. Pharm. Belg. 1981, 36, 203
7. J. Chromatogr. 1978, 145, 155
8. J. Chromatogr. 1984, 295, 248
9. Anal. Chem. 1980, 52, 1519–1522
10. J. Chromatogr. A. 1995, 718(2), 305–308
11. USP <1225>, Validation of Compendial Methods
12. Johns Hopkins Institute of Vaccine Safety, Excipients Database, 2022